tranylcypromine has been researched along with Neoplasm Metastasis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, L; Li, R; Wang, Y | 1 |
Calabretta, B; Cattelani, S; Chiodoni, C; Colombo, MP; Dominici, M; Fatatis, A; Ferrari-Amorotti, G; Grisendi, G; Manzotti, G; Rivasi, F; Shen, F; Soliera, AR | 1 |
2 other study(ies) available for tranylcypromine and Neoplasm Metastasis
Article | Year |
---|---|
Identification of selective and reversible LSD1 inhibitors with anti-metastasis activity by high-throughput docking.
Topics: Cell Line, Tumor; Demethylation; Enzyme Inhibitors; Histone Demethylases; Histones; Humans; Lysine; Methylation; Molecular Docking Simulation; Neoplasm Metastasis; Neoplasms; Structure-Activity Relationship | 2019 |
Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity.
Topics: Animals; Cadherins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Gene Silencing; Histone Demethylases; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, SCID; Microscopy, Fluorescence; Monoamine Oxidase Inhibitors; Neoplasm Invasiveness; Neoplasm Metastasis; Plasmids; Real-Time Polymerase Chain Reaction; Snail Family Transcription Factors; Transcription Factors; Tranylcypromine; Triple Negative Breast Neoplasms | 2014 |